4.8 Article

Laparoscopic Adjustable Gastric Banding and Other Devices for the Management of Obesity

期刊

CIRCULATION
卷 126, 期 6, 页码 774-785

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCULATIONAHA.111.040139

关键词

bariatric surgery; insulin resistance; metabolic syndrome X; obesity; weight loss

资金

  1. Medtronics Inc
  2. Abbott Pharmaceuticals
  3. Allergan Inc
  4. Servier
  5. Scientific Intake

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Peripheral Vascular Disease

Time in Target Range: the Future of Assessing Adequacy of Blood Pressure Control?

Markus P. Schlaich

HYPERTENSION (2023)

Article Endocrinology & Metabolism

Effect of Oral Contraception on Screening Tests for Primary Aldosteronism: A 10-Year Longitudinal Study

Jun Yang, Stella May Gwini, Lawrence J. Beilin, Markus Schlaich, Michael Stowasser, Morag J. Young, Peter J. Fuller, Trevor A. Mori

Summary: Oral contraception can increase the aldosterone to renin ratio, leading to false positive results in the screening for primary aldosteronism. Until more reliable criteria for primary aldosteronism screening in oral contraception users are established, alternative contraception methods should be considered.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2023)

Review Peripheral Vascular Disease

The urgency to regulate validation of automated blood pressure measuring devices: a policy statement and call to action from the world hypertension league

James E. Sharman, Pedro Ordunez, Tammy Brady, Gianfranco Parati, George Stergiou, Paul K. Whelton, Raj Padwal, Michael Hecht Olsen, Christian Delles, Aletta E. Schutte, Maciej Tomaszewski, Daniel T. Lackland, Nadia Khan, Richard J. McManus, Ross T. Tsuyuki, Xin-Hua Zhang, Lisa D. Murphy, Andrew E. Moran, Markus P. Schlaich, Norm R. C. Campbell

JOURNAL OF HUMAN HYPERTENSION (2023)

Article Multidisciplinary Sciences

Associations of physical activity levels, and attitudes towards physical activity with blood pressure among adults with high blood pressure in Bangladesh

Fakir M. Amirul Islam, Mohammad Ariful Islam, Mohammad Arzan Hosen, Elisabeth A. Lambert, Ralph Maddison, Gavin W. Lambert, Bruce R. Thompson

Summary: Engaging in high physical activity and having a positive attitude towards physical activity are associated with lower blood pressure levels in rural Bangladesh. Awareness programs should be implemented to promote the benefits of physical activity and increase participation in high physical activity.

PLOS ONE (2023)

Article Psychology, Clinical

Mental health and quality of life during weight loss in females with clinically severe obesity: a randomized clinical trial

Daniel J. van den Hoek, Clint T. Miller, Steve F. Fraser, Steve E. Selig, Toni Rice, Mariee Grima, Carolina Ika Sari, Gavin W. Lambert, John B. Dixon

Summary: This study explored the effects of dietary weight loss intervention, with and without exercise, on health-related quality of life, depressive symptoms, and anxiety in premenopausal women. The results showed that the addition of exercise to energy restriction had a significant positive impact on health-related quality of life, depressive symptoms, and state and trait anxiety scores. Exercise can improve mental health and quality of life in women with severe obesity without further weight loss.

JOURNAL OF BEHAVIORAL MEDICINE (2023)

Article Cardiac & Cardiovascular Systems

Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

Emanuele Barbato, Michel Azizi, Roland E. Schmieder, Lucas Lauder, Michael Boehm, Sofie Brouwers, Rosa Maria Bruno, Dariusz Dudek, Thomas Kahan, David E. Kandzari, Thomas F. Luscher, Gianfranco Parati, Atul Pathak, Flavio L. Ribichini, Markus P. Schlaich, Andrew S. P. Sharp, Isabella Sudano, Massimo Volpe, Costas Tsioufis, William Wijns, Felix Mahfoud

Summary: Since the publication of the 2018 ESC/ESH Guidelines, high-quality studies have confirmed the efficacy and safety of RDN in patients with hypertension. The consensus document recommends RDN as an adjunct treatment for uncontrolled resistant hypertension and for patients who cannot tolerate antihypertensive medications. A shared decision-making process is crucial, taking into account the patient's overall cardiovascular risk and the presence of hypertension-mediated organ damage or complications. Multidisciplinary hypertension teams involving experts and interventionalists are needed to evaluate indications and perform RDN procedures. Future research should focus on clinical outcomes and potential indications beyond hypertension.

EUROPEAN HEART JOURNAL (2023)

Review Cardiac & Cardiovascular Systems

Update on advanced interventional neuromodulatory approaches to lower blood pressure

Marcio Galindo Kiuchi, Revathy Carnagarin, Carl Schultz, Sharad Shetty, Natalie C. Ward, Carlos Eduardo Santos, Markus P. Schlaich

Summary: This article reviews interventional peripheral neuromodulatory approaches, such as catheter-based renal denervation (RDN), for reducing blood pressure. It discusses the importance of the sympathetic nervous system in hypertension and the efficacy of various interventional technologies like RDN in managing high blood pressure. The recent consensus statement by the European Society of Cardiology and the European Association of Percutaneous Cardiovascular Interventions highlights RDN as a supplementary treatment option for patients with uncontrolled resistant hypertension. Additionally, long-term safety and efficacy have been demonstrated for RDN, making it a valuable therapeutic choice for patients unlikely to adhere to long-term antihypertensive drug treatment.
Letter Cardiac & Cardiovascular Systems

Neural Network Modelling for Predicting Gene Variants Causative of Familial Hypercholesterolaemia in the Clinic

Janis M. Nolde, Jing Pang, Dick C. Chan, Natalie C. Ward, Ajmal Mian, Markus P. Schlaich, Gerald F. Watts

HEART LUNG AND CIRCULATION (2023)

Article Peripheral Vascular Disease

Outcomes Following Radiofrequency Renal Denervation According to Antihypertensive Medications: Subgroup Analysis of the Global SYMPLICITY Registry DEFINE

Felix Mahfoud, Giuseppe Mancia, Roland E. Schmieder, Luis Ruilope, Krzysztof Narkiewicz, Markus Schlaich, Bryan Williams, Flavio Ribichini, Joachim Weil, Khaled Almerri, Faisal Sharif, Lucas Lauder, Marianne Wanten, Martin Fahy, Michael Boehm

Summary: This study investigated whether the number or type of antihypertensive medications were associated with increased long-term blood pressure reductions and cardiovascular outcomes following radiofrequency renal denervation (RDN) in hypertensive patients. The results showed that radiofrequency RDN reduced blood pressure safely through 36 months, regardless of the number and type of baseline antihypertensive medication classes.

HYPERTENSION (2023)

Letter Surgery

Does a Measure for Weight Regain Provide a Useful Metric?

John B. Dixon

OBESITY SURGERY (2023)

Article Surgery

Development of a Bariatric Surgery Core Data Set for an International Registry

Karen D. D. Coulman, Katy Chalmers, Jane Blazeby, John Dixon, Lilian Kow, Ronald Liem, Dimitri J. J. Pournaras, Johan Ottosson, Richard Welbourn, Wendy Brown, Kerry Avery

Summary: This study developed a Core Registry Set (CRS) - core data to include in bariatric surgery registries globally, which is the first step towards unifying bariatric surgery registries internationally. We recommend the CRS is included as a minimum dataset in all bariatric registries worldwide. Adoption of the CRS will enable meaningful international comparisons of bariatric operations.

OBESITY SURGERY (2023)

Article Biochemistry & Molecular Biology

Comparing and Contrasting the Effects of the SGLT Inhibitors Canagliflozin and Empagliflozin on the Progression of Retinopathy

Lakshini Y. Herat, Jennifer R. Matthews, Elizabeth P. Rakoczy, Markus P. Schlaich, Vance B. Matthews

Summary: Diabetic retinopathy (DR) is a leading cause of end-stage blindness globally. SGLT2 inhibitors, such as Empagliflozin and Canagliflozin, show potential in alleviating the progression of DR.

FRONTIERS IN BIOSCIENCE-LANDMARK (2023)

Letter Medicine, General & Internal

Fluid retention and heart failure in the PRECISION trial - Reply

Markus P. Schlaich, Marc Bellet, Michael A. Weber, George L. Bakris, Ji-Guang Wang

LANCET (2023)

Article Peripheral Vascular Disease

Wisdom of the Crowd: insights gained from comparing predicted and observed effects of blood pressure lowering strategies

Sonali R. Gnanenthiran, Vivekanand Jha, Abdul Salam, Emily Atkins, Clara K. Chow, Mark R. Nelson, Mike Rakotz, Markus P. Schlaich, Aletta E. Schutte, Tim Usherwood, Anthony Rodgers

Summary: In this study, we assessed whether pooled cardiovascular expertise could accurately predict the efficacy and tolerability of both a novel and an established treatment option. A survey was conducted to collect predictions of blood pressure at 12 weeks and 52 weeks for participants in a trial called QUARTET, which involved two different treatment groups.

JOURNAL OF HUMAN HYPERTENSION (2023)

暂无数据